Is PLUG a toilet paper printing company?
Another one is sure to follow.
That's the only potential here.
Volume spikes on PUMPS and recedes on the DUMP.
A stock with low volume is undiscovered.
The volume will start increasing when word of the undervaluation spreads and earnings start rolling in.
Let's exrtrapolate, if Titan gets favorable FDA news, a 40% increase brings the pps to about $1.
So everyone is waiting for $1 on good FDA news and what pps on bad news, about .40, down 40%?
TTNP is no longer an investment. It's equivalent to placing a bet with a bookie.
This could hit new lows now.
You need to find a sense of humor and a low cap stock that will make you lots of money in place of this overpriced arf arf!
Buy stocks at the bottom. GTHP looks like a winner.
Don't you just hate it when stocks are pumped AFTER a run up?.
Buy stocks BEFORE they run up. Go go GTHP!
What's your problem? You are holding a dog that was down 16% on a huge up market day?
How does Mr. Higgins crying over spilled water help anyone?
I get it, he and a lot of people disagree with the FDA decision,
But he doesn't have a say in the decision. It's made by the FDA.
So it doesn't matter what he thinks after the horse left the stable.
What is the purpose of rehashing and nitpicking the minutes?
Does it lesson the pain?
Does it give you cover?
You can claim that you made the right decision buying TTNP
and it's the FDA that got it wrong.
Is that it?
To enlighten you?
Or are you too far gone into the darkness of the abyss to comprehend facts and reason?
Never look a gift horse in the mouth.
Sunil and Rubin each spent about $20,000 of pocket change .
If thy knew something, they would have mortgaged their homes.
Just about all the longs on this MB bought more shares than those two clowns and they haven't got a clue what will happen.
Do you think that Sunil and Rubin knew that the FDA would issue a CRL?
Your premise and conclusion are out of kilter.
A GTHP insider recently bought 1,250,000 shares .... now that you can extrapolate as having some significance.
If Sunil buys a cup of java, would you assume that the price of coffee beans is going up?
"Enanta Pharmaceuticals, Inc., a biotechnology company, engages in the development of small molecule drugs for the infectious disease areas. Its product candidates include ABT-450, an inhibitor of NS3 protease that is in Phase III clinical trials for the treatment of hepatitis C virus (HCV) infections."
Some is late to the party and back of the line.
Lots of hype but no results.
Imminent FDA approval will send the stock through the roof.
Market cap is only $30 million.
Over 60 million PAP smear tests are taken annually.
GTHP's biophotonic scan is noninvasive, more accurate and produces instantaneous test results.
Interim data for cherry picking sub groups?
That never works either.
A waste of time and funds.
Chapter 11 awaits.
to double his pleasure .... just your average hedgie raping the baggies.
Who conned you into this penny scam?
Publications that have nothing to do with INO.
Ho about Phase 3 trial?